Next Article in Journal
The Evolving Paradigm of Antibody–Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases
Previous Article in Journal
From Tyrosine Kinases to Tyrosine Phosphatases: New Therapeutic Targets in Cancers and Beyond
Previous Article in Special Issue
Antibody–Drug Conjugates: Ushering in a New Era of Cancer Therapy
 
 
Editorial

Article Versions Notes

Pharmaceutics 2024, 16(7), 889; https://doi.org/10.3390/pharmaceutics16070889
Action Date Notes Link
article xml file uploaded 1 July 2024 10:50 CEST Original file -
article xml uploaded. 1 July 2024 10:50 CEST Update https://www.mdpi.com/1999-4923/16/7/889/xml
article pdf uploaded. 1 July 2024 10:50 CEST Version of Record https://www.mdpi.com/1999-4923/16/7/889/pdf
article html file updated 1 July 2024 10:51 CEST Original file https://www.mdpi.com/1999-4923/16/7/889/html
Back to TopTop